Infection and atherosclerosis
Atherosclerosis is an inflammatory disease
Stable versus unstable atherosclerosis: Clinical aspects
Diet and atherosclerosis
Role of infections in atherosclerosis
Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies
Functionality of specific immunity in atherosclerosis
Autoimmunity and atherosclerosis
Molecular mediators of arterial inflammation: A role for microbial products?
Viruses and atherosclerosis: A critical review of the epidemiologic evidence
Viral activation of the coagulation cascade
Atherosclerosis induced by infection with Marek’s disease herpesvirus in chickens
Coronary artery disease after heart transplantation and its relation to cytomegalovirus
Cytomegalovirus is involved in vascular pathology
Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis
Enteroviruses and myocardial infarction
Cytomegalovirus vaccine
Chlamydia pneumoniae and atherosclerosis: Links to the disease process
Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
Pathologic manifestation of chlamydial infection
Epidemiology of Chlamydia pneumoniae in atherosclerosis
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells
Value of animal models for Chlamydia pneumoniae -related atherosclerosis
Animal models of chlamydia and atherosclerosis
Mouse models of Chlamydia pneumoniae infection and atherosclerosis
Transgene as vaccine for chlamydia
Helicobacter and atherosclerosis
Dental infections and atherosclerosis
Multiple infections in carotid atherosclerotic plaques
Emerging role of antibiotics in atherosclerosis
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics
Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: Design issues
Fulfillment of Koch’s postulates and the causes of atherosclerosis
How to design studies to confirm a link between bacterial infection and atherosclerosis
Designing studies to confirm a link between viral infection and atherosclerosis
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis
How to design vaccination trials to prevent atherosclerosis